To develop practical and effective clinical diagnosis and treatment schemes for the control of novel coronavirus pneumonia.
By retrospectively analyzing the clinical epidemiological characteristics of the novel coronavirus pneumonia and the current diagnosis and treatment schemes, as well as in-depth analyzing the disease development process and outcome trends of NCP patients to develop practical and effective clinical diagnosis and treatment schemes and provide guarantee for the rapid control of the epidemic.
Combination Product: systemic treatment
Oxygen therapy, antiviral therapy, antibiotics, hormones, globulin
- Patients confirmed with novel coronavirus pneumonia. The Diagnostic criteria refer to "Pneumonitis Diagnosis and Treatment Scheme for Novel Coronavirus Infection (Trial Version 5)";
- Physician judged the patient was not suitable for this clinical trial.